Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to determine the maximum tolerable dose and safety of intravaginal curcumin in a normal population of women (women with no evidence of cervical cytological abnormalities by pap testing).


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01035580
Study type Interventional
Source Emory University
Contact
Status Completed
Phase Phase 1
Start date January 2010
Completion date January 2012

See also
  Status Clinical Trial Phase
Completed NCT01505920 - Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial Phase 3
Completed NCT01014026 - Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention Phase 3
Completed NCT00377845 - Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear. Phase 0
Completed NCT02910388 - LLETZ Under Direct Colposcopic Vision N/A
Completed NCT00596258 - A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL) Phase 2
Completed NCT03763565 - Effectiveness of HPV Vaccine in Thai Adult Women
Completed NCT04415840 - Lugol's Solution in Addition to Acetic Acid During Colposcopy
Recruiting NCT04783805 - Conservative Management of HSIL in Patients With Future Pregnancy Aspiration
Completed NCT04326049 - LLETZ With Videocolposcopy Versus LLETZ With Binocular Colposcopy N/A
Completed NCT02515162 - Fischer Cone Biopsy Excisor Versus Loop Excision Procedure for Conization N/A
Completed NCT02486471 - Hemostatic Procedure After Biopsy of the Cervix N/A
Completed NCT01405768 - Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs) Phase 2
Completed NCT00264732 - A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix Phase 2/Phase 3
Completed NCT03296566 - The SAFE Study: Satisfaction and Adherence to Follow-Up With Colposcopy Exams N/A
Completed NCT02346227 - Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix Phase 3
Completed NCT02330471 - Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial Phase 3
Completed NCT01639820 - Comparison of Pelvic Lymphadenectomy Versus Isolated Sentinel Lymph Node Biopsy Procedure for Early Stages of Cervical Cancers : a Multicenter Study With Evaluation of Medico-economic Impacts N/A
Completed NCT00285207 - Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix Phase 2
Recruiting NCT05225493 - HIV Indicator Diseases in Hospital and Primary Care
Completed NCT01034358 - Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Phase 4